ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
RCPI was delisted on the 4th of November, 2015.
55 hedge funds and large institutions have $2.72M invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 15 closing their positions.
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
18% less funds holding
Funds holding: 67 → 55 (-12)
39% less call options, than puts
Call options by funds: $40K | Put options by funds: $66K
49% less capital invested
Capital invested by funds: $5.36M → $2.72M (-$2.64M)
73% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$74.4K |
| 2 |
Comerica Bank
Dallas,
Texas
|
+$42.1K |
| 3 |
Millennium Management
New York
|
+$25.6K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$15.9K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
-$891K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$33K |
| 3 |
Goldman Sachs
New York
|
-$20.9K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$11.4K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$10K |
RCPI Hedge Fund Activity: Q4 2014 in Review
55 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q4 2014, worth a combined $2.72M — down 49% from $5.36M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of RCPI and 4 opened new positions — a net loss of 11 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Susquehanna International Group, adding an estimated $74.4K. The largest seller was Goldman Capital Management, cutting an estimated $891K.
- 55 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q4 2014, down from 67 in Q3 2014.
- Funds reported $2.72M of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, down 49% quarter-over-quarter.
- 4 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 15 closed out, a net change of -11 holders.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Susquehanna International Group, an estimated $74.4K added.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Goldman Capital Management, an estimated $891K sold.
Based on aggregated 13F filings for Q4 2014.